Literature DB >> 22516575

New insights into pathways that determine the link between infection and thrombosis.

M Levi1, T van der Poll, M Schultz.   

Abstract

Severe infection is often linked to prothrombotic events. Indeed, haemostatic abnormalities are encountered in most cases of infection, ranging from an increase in sensitive markers for coagulation activation or insignificant laboratory changes to gross activation of coagulation that may result in localised thrombotic complications or disseminated intravascular coagulation. Systemic inflammation as a consequence of infection results in activation of coagulation, due to tissue factor-mediated thrombin generation, down-regulation of physiological anticoagulant mechanisms, and inhibition of fibrinolysis. Pro-inflammatory cytokines, immune cells and the endothelium form the interface on which differential effects on the coagulation and fibrinolysis pathways may ensue. Conversely, activation of the coagulation system may importantly affect inflammatory responses by direct and indirect mechanisms. Apart from the general coagulation response to inflammation associated with severe infection, specific infections may cause distinct features, such as haemorrhagic fever or thrombotic microangiopathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22516575

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  32 in total

1.  Endothelial injury in sepsis.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Intensive Care Med       Date:  2013-08-08       Impact factor: 17.440

2.  Bone Marrow Mesenchymal Stem Cells Alleviate Extracellular Kynurenine Levels, as Detected by High-Performance Liquid Chromatography.

Authors:  Yuanyuan Wang; Jing Zhao; Lifei Tan; Yueyue Huang; Dequan Li; Shichao Quan; Min Li; Jingye Pan
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 3.  Inflammatory bowel disease and thromboembolism.

Authors:  Petros Zezos; Georgios Kouklakis; Fred Saibil
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 4.  Pro-inflammatory genetic markers of atherosclerosis.

Authors:  Egle Incalcaterra; Giulia Accardi; Carmela Rita Balistreri; Gregorio Caimi; Giuseppina Candore; Marco Caruso; Calogero Caruso
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

Review 5.  Pathophysiologic mechanisms in septic shock.

Authors:  Elizabeth G King; Gustavo J Bauzá; Juan R Mella; Daniel G Remick
Journal:  Lab Invest       Date:  2013-09-23       Impact factor: 5.662

6.  Sepsis-Associated Coagulopathy.

Authors:  Ecaterina Scarlatescu; Dana Tomescu; Sorin Stefan Arama
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-11-08

7.  Fluid resuscitation with 0.9% saline alters haemostasis in an ovine model of endotoxemic shock.

Authors:  Margaret R Passmore; Nchafatso G Obonyo; Liam Byrne; Ai-Ching Boon; Sara D Diab; Kimble R Dunster; Yoke L Fung; Michelle M Spanevello; Mohd H Fauzi; Sanne E Pedersen; Gabriela Simonova; Chris M Anstey; Kiran Shekar; John-Paul Tung; Kathryn Maitland; John F Fraser
Journal:  Thromb Res       Date:  2019-02-12       Impact factor: 10.407

8.  Lysophosphatidic Acid Receptor 3 Suppress Neutrophil Extracellular Traps Production and Thrombosis During Sepsis.

Authors:  Shengqiang Pei; Chuansheng Xu; Jianqiu Pei; Ruifeng Bai; Rui Peng; Tiewei Li; Junjie Zhang; Xiangfeng Cong; Jerold Chun; Fang Wang; Xi Chen
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

9.  The discovery of dabigatran etexilate.

Authors:  Joanne van Ryn; Ashley Goss; Norbert Hauel; Wolfgang Wienen; Henning Priepke; Herbert Nar; Andreas Clemens
Journal:  Front Pharmacol       Date:  2013-02-12       Impact factor: 5.810

10.  Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic background.

Authors:  Kelsey J Weigel; Laura Rues; Edward J Doyle; Cassandra L Buchheit; John G Wood; Ryan J Gallagher; Laura E Kelly; Jeffrey D Radel; Kenneth A Bradley; Steven M LeVine
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.